About Us Services Careers FAQ Contact Us 0
Home Medical Devices TB Diagnostics Market Size, Growth & Statistics Report | 2030
TB Diagnostics Market
Select Regional / Country Report
Global Europe North America Asia Pacific

TB Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Nucleic Acid Testing (NAT), Skin Test / Mantoux Test (TST), Blood Test / Serology Test, SMEAR Microscopy, Cultured-Based Tests, Radiography Tests, Others), By End-User (Hospitals and Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics and Research Facilities) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRMD1557DR
Last Updated : October 29, 2024
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global TB Diagnostics Market Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Nucleic Acid Testing (NAT)
        1. By Value
      3. Skin Test / Mantoux Test (TST)
        1. By Value
      4. Blood Test / Serology Test
        1. By Value
      5. SMEAR Microscopy
        1. By Value
      6. Cultured-Based Tests
        1. By Value
      7. Radiography Tests
        1. By Value
      8. Others
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Diagnostic Laboratories
        1. By Value
      3. Physician’s Office Laboratories
        1. By Value
      4. Reference Laboratories
        1. By Value
      5. Academics and Research Facilities
        1. By Value
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Nucleic Acid Testing (NAT)
        1. By Value
      3. Skin Test / Mantoux Test (TST)
        1. By Value
      4. Blood Test / Serology Test
        1. By Value
      5. SMEAR Microscopy
        1. By Value
      6. Cultured-Based Tests
        1. By Value
      7. Radiography Tests
        1. By Value
      8. Others
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Diagnostic Laboratories
        1. By Value
      3. Physician’s Office Laboratories
        1. By Value
      4. Reference Laboratories
        1. By Value
      5. Academics and Research Facilities
        1. By Value
    4. U.S.
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Nucleic Acid Testing (NAT)
          1. By Value
        3. Skin Test / Mantoux Test (TST)
          1. By Value
        4. Blood Test / Serology Test
          1. By Value
        5. SMEAR Microscopy
          1. By Value
        6. Cultured-Based Tests
          1. By Value
        7. Radiography Tests
          1. By Value
        8. Others
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Diagnostic Laboratories
          1. By Value
        3. Physician’s Office Laboratories
          1. By Value
        4. Reference Laboratories
          1. By Value
        5. Academics and Research Facilities
          1. By Value
    5. Canada
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Nucleic Acid Testing (NAT)
        1. By Value
      3. Skin Test / Mantoux Test (TST)
        1. By Value
      4. Blood Test / Serology Test
        1. By Value
      5. SMEAR Microscopy
        1. By Value
      6. Cultured-Based Tests
        1. By Value
      7. Radiography Tests
        1. By Value
      8. Others
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Diagnostic Laboratories
        1. By Value
      3. Physician’s Office Laboratories
        1. By Value
      4. Reference Laboratories
        1. By Value
      5. Academics and Research Facilities
        1. By Value
    4. U.K.
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Nucleic Acid Testing (NAT)
          1. By Value
        3. Skin Test / Mantoux Test (TST)
          1. By Value
        4. Blood Test / Serology Test
          1. By Value
        5. SMEAR Microscopy
          1. By Value
        6. Cultured-Based Tests
          1. By Value
        7. Radiography Tests
          1. By Value
        8. Others
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Diagnostic Laboratories
          1. By Value
        3. Physician’s Office Laboratories
          1. By Value
        4. Reference Laboratories
          1. By Value
        5. Academics and Research Facilities
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Nucleic Acid Testing (NAT)
        1. By Value
      3. Skin Test / Mantoux Test (TST)
        1. By Value
      4. Blood Test / Serology Test
        1. By Value
      5. SMEAR Microscopy
        1. By Value
      6. Cultured-Based Tests
        1. By Value
      7. Radiography Tests
        1. By Value
      8. Others
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Diagnostic Laboratories
        1. By Value
      3. Physician’s Office Laboratories
        1. By Value
      4. Reference Laboratories
        1. By Value
      5. Academics and Research Facilities
        1. By Value
    4. China
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Nucleic Acid Testing (NAT)
          1. By Value
        3. Skin Test / Mantoux Test (TST)
          1. By Value
        4. Blood Test / Serology Test
          1. By Value
        5. SMEAR Microscopy
          1. By Value
        6. Cultured-Based Tests
          1. By Value
        7. Radiography Tests
          1. By Value
        8. Others
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Diagnostic Laboratories
          1. By Value
        3. Physician’s Office Laboratories
          1. By Value
        4. Reference Laboratories
          1. By Value
        5. Academics and Research Facilities
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Nucleic Acid Testing (NAT)
        1. By Value
      3. Skin Test / Mantoux Test (TST)
        1. By Value
      4. Blood Test / Serology Test
        1. By Value
      5. SMEAR Microscopy
        1. By Value
      6. Cultured-Based Tests
        1. By Value
      7. Radiography Tests
        1. By Value
      8. Others
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Diagnostic Laboratories
        1. By Value
      3. Physician’s Office Laboratories
        1. By Value
      4. Reference Laboratories
        1. By Value
      5. Academics and Research Facilities
        1. By Value
    4. UAE
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Nucleic Acid Testing (NAT)
          1. By Value
        3. Skin Test / Mantoux Test (TST)
          1. By Value
        4. Blood Test / Serology Test
          1. By Value
        5. SMEAR Microscopy
          1. By Value
        6. Cultured-Based Tests
          1. By Value
        7. Radiography Tests
          1. By Value
        8. Others
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Diagnostic Laboratories
          1. By Value
        3. Physician’s Office Laboratories
          1. By Value
        4. Reference Laboratories
          1. By Value
        5. Academics and Research Facilities
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Nucleic Acid Testing (NAT)
        1. By Value
      3. Skin Test / Mantoux Test (TST)
        1. By Value
      4. Blood Test / Serology Test
        1. By Value
      5. SMEAR Microscopy
        1. By Value
      6. Cultured-Based Tests
        1. By Value
      7. Radiography Tests
        1. By Value
      8. Others
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Diagnostic Laboratories
        1. By Value
      3. Physician’s Office Laboratories
        1. By Value
      4. Reference Laboratories
        1. By Value
      5. Academics and Research Facilities
        1. By Value
    4. Brazil
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Nucleic Acid Testing (NAT)
          1. By Value
        3. Skin Test / Mantoux Test (TST)
          1. By Value
        4. Blood Test / Serology Test
          1. By Value
        5. SMEAR Microscopy
          1. By Value
        6. Cultured-Based Tests
          1. By Value
        7. Radiography Tests
          1. By Value
        8. Others
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Diagnostic Laboratories
          1. By Value
        3. Physician’s Office Laboratories
          1. By Value
        4. Reference Laboratories
          1. By Value
        5. Academics and Research Facilities
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. TB Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Thermo Fisher Scientific Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Becton Dickinson and Company
    3. Hoffmann-La Roche Ltd.
    4. Qiagen NV
    5. Hologic Inc.
    6. BioMerieux SA
    7. Oxford Immunotec Ltd.
    8. Cepheid Inc.
    9. Akonni Biosystems Inc.
    10. PAR Pharmaceuticals
    11. Alere Inc. (Abbott)
    12. Lionex GmbH
    13. Creative Diagnostics
    14. Hain Life Science.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Clinical Diagnostics Market Size The global clinical diagnostics market size was valued at USD 84.18 billion in 2024 and is projected to reach from USD 98.21 billion in 2025 to USD 187.78 billion by 2033, exhibiting a CAGR of 6.48% during the f
Buy Now
Global Report
The global companion diagnostics market size was valued at USD 5.37 billion in 2023. It is estimated to reach USD 15.87 billion by 2032, growing at a CAGR of 12.8% during the forecast period (2024–2032). The growing prevalence of chronic diseas
Buy Now
Global Report
Hematology Diagnostics Market Size & Trends The global hematology diagnostics market size was valued at USD 8.34 billion in 2022. It is projected to reach USD 13.50 billion by 2031, growing at a CAGR of 5.5% during the forecast period (2023–2031
Buy Now
Global Report
Molecular Diagnostics Market Size & Trends The global molecular diagnostics market size was valued at USD 14.93 billion in 2023 and is projected to reach USD 33.40 billion by 2032, growing at a CAGR of 9.36% during the forecast period (2024–2032).
Buy Now
Global Report
The global transplant diagnostics market size was valued at USD 3,550 million in 2019 and is expected to grow with a CAGR of 7.4% during the forecast period, 2020–2029. Organ transplantation is a surgical procedure of removing healthy org
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.